Mutations in the coding region or the intron region of COL3A1 gene leads to an arterial disease termed as Ehlers-Danlos syndrome (EDS) and affects patient survival [2-4]. This evidence concerns the gene COL3A1 and Ehlers-Danlos syndrome.